Merck & Co., Inc. (MRK)
115.84
+2.47
(+2.18%)
USD |
NYSE |
Feb 03, 16:00
116.00
+0.16
(+0.14%)
Pre-Market: 20:00
Merck EPS Diluted (Quarterly) : 1.191 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 7.86 |
| Cidara Therapeutics, Inc. | -3.096 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.962B |
| Revenue (Quarterly) | 16.40B |
| Total Expenses (Quarterly) | 13.44B |
| Enterprise Value | 310.70B |
| Gross Profit Margin (Quarterly) | 79.73% |
| Profit Margin (Quarterly) | 18.06% |
| Earnings Yield | 6.28% |
| Operating Earnings Yield | 9.22% |
| Normalized Earnings Yield | 7.422 |